Related Experiment Video
Updated: Aug 12, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
Can modulation of endothelial nitric oxide synthase explain the vasculoprotective actions of statins?
1Yale University School of Medicine, Dept of Pharmacology, Boyer Center for Molecular Medicine, 295 Congress Avenue, New Haven, CT 06536, USA. william.sessa@yale.edu
Abstract:
Statin-based drugs are the mainstay of therapy for coronary artery disease. Recent insights into the cellular mechanisms of this class of drugs suggest that modulation of nitric oxide synthesis contributes to their beneficial actions. These effects are independent of their lipid-lowering effects and result in enhanced nitric oxide release.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Nitric Oxide Signaling Pathway
Antihypertensive Drugs: Vasodilators
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

